Emerging technologies for cardiac tissue engineering and artificial hearts
暂无分享,去创建一个
Yu Wang | Yuanjin Zhao | Dongyu Xu | Lingyu Sun | Yu Wang | Lingyu Sun | Dongyu Xu | Yuanjin Zhao
[1] G. Wallace,et al. Development of 3D printable graphene oxide based bio-ink for cell support and tissue engineering , 2022, Frontiers in Bioengineering and Biotechnology.
[2] Changyong Wang,et al. A Conductive Bioengineered Cardiac Patch for Myocardial Infarction Treatment by Improving Tissue Electrical Integrity , 2022, Advanced healthcare materials.
[3] J. Fradette,et al. Biofabrication of Sodium Alginate Hydrogel Scaffolds for Heart Valve Tissue Engineering , 2022, International journal of molecular sciences.
[4] K. Parker,et al. Recreating the heart’s helical structure-function relationship with focused rotary jet spinning , 2022, Science.
[5] S. Jana,et al. Strategies for development of decellularized heart valve scaffolds for tissue engineering. , 2022, Biomaterials.
[6] Gaoyang Guo,et al. Development of Innovative Biomaterials and Devices for the Treatment of Cardiovascular Diseases , 2022, Advanced materials.
[7] M. Khodaei,et al. Electro-conductive 3D printed polycaprolactone/gold nanoparticles nanocomposite scaffolds for myocardial tissue engineering. , 2022, Journal of the mechanical behavior of biomedical materials.
[8] J. Lewis,et al. Programming Cellular Alignment in Engineered Cardiac Tissue via Bioprinting Anisotropic Organ Building Blocks , 2022, Advanced materials.
[9] A. Shamloo,et al. Tubular TPU/SF nanofibers covered with chitosan-based hydrogels as small-diameter vascular grafts with enhanced mechanical properties , 2022, Scientific Reports.
[10] Paola Sanjuan‐Alberte,et al. Electrospun piezoelectric scaffolds for cardiac tissue engineering. , 2022, Biomaterials advances.
[11] N. Cao,et al. Reprogramming of fibroblasts into expandable cardiovascular progenitor cells via small molecules in xeno-free conditions , 2022, Nature Biomedical Engineering.
[12] Mitchell A. Kuss,et al. Tri‐Layered and Gel‐Like Nanofibrous Scaffolds with Anisotropic Features for Engineering Heart Valve Leaflets , 2022, Advanced healthcare materials.
[13] Mary E. Haas,et al. Association of Habitual Alcohol Intake With Risk of Cardiovascular Disease , 2022, JAMA network open.
[14] Karina H. Nakayama,et al. Decellularization Strategies for Regenerating Cardiac and Skeletal Muscle Tissues , 2022, Frontiers in Bioengineering and Biotechnology.
[15] Wenguang Liu,et al. Functional hydrogels for the treatment of myocardial infarction , 2022, NPG Asia Materials.
[16] D. Hutmacher,et al. Spatially Heterogeneous Tubular Scaffolds for In Situ Heart Valve Tissue Engineering Using Melt Electrowriting , 2022, Advanced Functional Materials.
[17] Benjamin Bowe,et al. Long-term cardiovascular outcomes of COVID-19 , 2022, Nature Medicine.
[18] Charlie C. L. Wang,et al. A multi-axis robot-based bioprinting system supporting natural cell function preservation and cardiac tissue fabrication , 2022, Bioactive materials.
[19] Changyou Gao,et al. Multifunctional elastomer cardiac patches for preventing left ventricle remodeling after myocardial infarction in vivo. , 2022, Biomaterials.
[20] R. Passier,et al. Generation and Culture of Cardiac Microtissues in a Microfluidic Chip with a Reversible Open Top Enables Electrical Pacing, Dynamic Drug Dosing and Endothelial Cell Co-Culture , 2021, bioRxiv.
[21] M. Radisic,et al. A framework for developing sex-specific engineered heart models , 2021, Nature Reviews Materials.
[22] F. Benesch-Lee,et al. Hyaluronic Acid Regulates Heart Valve Interstitial Cell Contraction in Fibrin-based Scaffolds. , 2021, Acta biomaterialia.
[23] D. Davis,et al. State‐of‐play for cellular therapies in cardiac repair and regeneration , 2021, Stem cells.
[24] Changyong Wang,et al. Natural Melanin/Alginate Hydrogels Achieve Cardiac Repair through ROS Scavenging and Macrophage Polarization , 2021, Advanced science.
[25] J. Qian,et al. Direct in vivo reprogramming with non-viral sequential targeting nanoparticles promotes cardiac regeneration. , 2021, Biomaterials.
[26] Baolin Guo,et al. 3D bioprinting in cardiac tissue engineering , 2021, Theranostics.
[27] G. Zapata-Sudo,et al. Mesenchymal Stem Cells Therapies on Fibrotic Heart Diseases , 2021, International journal of molecular sciences.
[28] Jianhua Liu,et al. Reactive oxygen species-based nanomaterials for the treatment of myocardial ischemia reperfusion injuries , 2021, Bioactive materials.
[29] Yuanjin Zhao,et al. Induced cardiomyocytes-integrated conductive microneedle patch for treating myocardial infarction , 2021 .
[30] G. Vunjak‐Novakovic,et al. Harnessing organs-on-a-chip to model tissue regeneration. , 2021, Cell stem cell.
[31] Junjun Li,et al. Therapeutic efficacy of large aligned cardiac tissue derived from induced pluripotent stem cell in a porcine ischemic cardiomyopathy model. , 2021, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[32] Xiaodong Cao,et al. Bioactive glass activates VEGF paracrine signaling of cardiomyocytes to promote cardiac angiogenesis. , 2021, Materials science & engineering. C, Materials for biological applications.
[33] A. Tamayol,et al. Biofabrication of natural hydrogels for cardiac, neural, and bone Tissue engineering Applications , 2021, Bioactive materials.
[34] R. Choi,et al. Ceramides and other sphingolipids as drivers of cardiovascular disease , 2021, Nature Reviews Cardiology.
[35] R. Augustine,et al. Stem cell-based approaches in cardiac tissue engineering: controlling the microenvironment for autologous cells. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[36] T. Dvir,et al. One‐Step 3D Printing of Heart Patches with Built‐In Electronics for Performance Regulation , 2021, Advanced science.
[37] Sung Yun Hann,et al. 4D Printed Cardiac Construct with Aligned Myofibers and Adjustable Curvature for Myocardial Regeneration. , 2021, ACS applied materials & interfaces.
[38] Haitao Liu,et al. 3D printing of tissue engineering scaffolds: a focus on vascular regeneration , 2021, Bio-design and manufacturing.
[39] H. Baumgartner,et al. The year in cardiovascular medicine 2020: valvular heart disease , 2021, European heart journal.
[40] Nanbo Liu,et al. Advances in 3D bioprinting technology for cardiac tissue engineering and regeneration , 2020, Bioactive materials.
[41] Qian Yu,et al. Release of VEGF and BMP9 from injectable alginate based composite hydrogel for treatment of myocardial infarction , 2020, Bioactive materials.
[42] B. Leal,et al. Vascular Tissue Engineering: Polymers and Methodologies for Small Caliber Vascular Grafts , 2021, Frontiers in Cardiovascular Medicine.
[43] P. Zorlutuna,et al. Electrically conductive 3D printed Ti3C2Tx MXene-PEG composite constructs for cardiac tissue engineering. , 2020, Acta biomaterialia.
[44] R. Cameron,et al. Modulating hESC-derived cardiomyocyte and endothelial cell function with triple-helical peptides for heart tissue engineering. , 2020, Biomaterials.
[45] Samin K. Sharma,et al. Cardiac procedural myocardial injury, infarction, and mortality in patients undergoing elective percutaneous coronary intervention: a pooled analysis of patient-level data. , 2020, European heart journal.
[46] Deok‐Ho Kim,et al. 3D Bioprinting of Mechanically Tuned Bioinks derived from Cardiac Decellularized Extracellular Matrix. , 2020, Acta biomaterialia.
[47] J. Jacot,et al. Engineering Myocardium for Heart Regeneration—Advancements, Considerations, and Future Directions , 2020, Frontiers in Cardiovascular Medicine.
[48] L. Fields,et al. Engineered cell-degradable poly(2-alkyl-2-oxazoline) hydrogel for epicardial placement of mesenchymal stem cells for myocardial repair , 2020, Biomaterials.
[49] Yu Song,et al. Silk‐Based Biomaterials for Cardiac Tissue Engineering , 2020, Advanced healthcare materials.
[50] Randall J. Lee,et al. Injectable Drug‐Releasing Microporous Annealed Particle Scaffolds for Treating Myocardial Infarction , 2020, Advanced functional materials.
[51] M. Schwerzmann,et al. 2020 ESC Guidelines for the management of adult congenital heart disease. , 2020, European heart journal.
[52] A. Urbanska,et al. Electrospinning for tissue engineering applications , 2020 .
[53] M. Gatzoulis,et al. Heart transplantation at a single tertiary adult congenital heart disease centre: Too little, too late? , 2020, International journal of cardiology.
[54] Doris A Taylor,et al. Tissue-engineered human embryonic stem cell-containing cardiac patches: evaluating recellularization of decellularized matrix , 2020, Journal of tissue engineering.
[55] Wuqiang Zhu,et al. Nanoparticle-Mediated Drug Delivery for Treatment of Ischemic Heart Disease , 2020, Frontiers in Bioengineering and Biotechnology.
[56] Sung Yun Hann,et al. 4D physiologically adaptable cardiac patch: A 4-month in vivo study for the treatment of myocardial infarction , 2020, Science Advances.
[57] A. B. Van de Walle,et al. Flow with variable pulse frequencies accelerates vascular recellularization and remodeling of a human bioscaffold. , 2020, Journal of biomedical materials research. Part A.
[58] R. Virmani,et al. Vulnerable plaques and patients: state-of-the-art. , 2020, European heart journal.
[59] A. Marsden,et al. Spontaneous reversal of stenosis in tissue-engineered vascular grafts , 2020, Science Translational Medicine.
[60] D. K. Arrell,et al. Cardiopoietic stem cell therapy restores infarction-altered cardiac proteome , 2020, npj Regenerative Medicine.
[61] D. Cho,et al. In vivo priming of human mesenchymal stem cells with hepatocyte growth factor–engineered mesenchymal stem cells promotes therapeutic potential for cardiac repair , 2020, Science Advances.
[62] Guoyou Huang,et al. Solvent-Free Fabrication of Carbon Nanotube/Silk Fibroin Electrospun Matrices for Enhancing Cardiomyocyte Functionalities. , 2020, ACS biomaterials science & engineering.
[63] T. Dvir,et al. Electrospun Fibrous PVDF‐TrFe Scaffolds for Cardiac Tissue Engineering, Differentiation, and Maturation , 2020, Advanced Materials Technologies.
[64] Shu‐hong Li,et al. A conductive cell-delivery construct as a bioengineered patch that can improve electrical propagation and synchronize cardiomyocyte contraction for heart repair. , 2020, Journal of controlled release : official journal of the Controlled Release Society.
[65] L. Niklason,et al. Tissue-Engineered Vascular Grafts with Advanced Mechanical Strength from Human iPSCs. , 2020, Cell stem cell.
[66] Yi Hong,et al. Current Advances in Biodegradable Synthetic Polymer based Cardiac Patches. , 2020, Journal of biomedical materials research. Part A.
[67] Sebastien G M Uzel,et al. Biomanufacturing of organ-specific tissues with high cellular density and embedded vascular channels , 2019, Science Advances.
[68] R. Khouzam,et al. A Comparative Analysis of Mitraclip Versus Mitral Valve-In-Valve Replacement for High-Risk Patients With Severe Mitral Regurgitation After Transcatheter Aortic Valve Replacement. , 2019, Current problems in cardiology.
[69] Zhen Gu,et al. Cardiac cell–integrated microneedle patch for treating myocardial infarction , 2018, Science Advances.
[70] P. Ma,et al. Interwoven Aligned Conductive Nanofiber Yarn/Hydrogel Composite Scaffolds for Engineered 3D Cardiac Anisotropy. , 2017, ACS nano.
[71] I. Domian,et al. Recreating the Cardiac Microenvironment in Pluripotent Stem Cell Models of Human Physiology and Disease. , 2017, Trends in cell biology.
[72] N. Bursac,et al. Tissue-engineered 3-dimensional (3D) microenvironment enhances the direct reprogramming of fibroblasts into cardiomyocytes by microRNAs , 2016, Scientific Reports.
[73] Teruo Okano,et al. Human iPS cell-engineered cardiac tissue sheets with cardiomyocytes and vascular cells for cardiac regeneration , 2014, Scientific Reports.
[74] N. Bursac,et al. Controlling the structural and functional anisotropy of engineered cardiac tissues , 2014, Biofabrication.
[75] Kumaraswamy Nanthakumar,et al. Design and formulation of functional pluripotent stem cell-derived cardiac microtissues , 2013, Proceedings of the National Academy of Sciences.
[76] Jiyong Jin,et al. Transplantation of mesenchymal stem cells within a poly(lactide‐co‐ɛ‐caprolactone) scaffold improves cardiac function in a rat myocardial infarction model , 2009, European journal of heart failure.
[77] J. Huard,et al. Muscle-derived stem cells for tissue engineering and regenerative therapy. , 2007, Biomaterials.
[78] Diane Hoffman-Kim,et al. Comparison of three myofibroblast cell sources for the tissue engineering of cardiac valves. , 2005, Tissue engineering.